Federal Register: FDA Issues Notice of Availability for Strategy Document on Facilitating Chemistry, Manufacturing, and Controls Readiness for Products With Accelerated Clinical Development
July 23, 2026
July 23, 2026
WASHINGTON, July 23 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
The Food and Drug Administration (FDA) is announcing the publication of FDA's Strategy Document on Facilitating Chemistry, Manufacturing, and Controls Readiness for Products With Accelerated Clinical Development, which outlines actions FDA has taken and the Agency's plans for fiscal years 2026-2 . . .
* * *
The Food and Drug Administration (FDA) is announcing the publication of FDA's Strategy Document on Facilitating Chemistry, Manufacturing, and Controls Readiness for Products With Accelerated Clinical Development, which outlines actions FDA has taken and the Agency's plans for fiscal years 2026-2 . . .